The Research and Development team at AOBiome Therapeutics spearheads the innovation and advancement of microbiome-based therapies aimed at treating inflammatory conditions. This multidisciplinary team collaborates on preclinical and clinical research, ensuring rigorous evaluation of the therapeutic candidates while navigating regulatory pathways to facilitate successful product submissions. Their efforts are crucial in translating scientific discoveries into safe and effective treatment options for patients.
View all